A Non-interventional Registration Study of Monotherapy or Combination Regimens Based on Camrelizumab or Famitinib for the Treatment of Cervical Cancer
Clinical trial NCT07266350 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07266350
- Sponsor
- Qi Zhou
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-12-30
- Primary completion
- 2028-12-30
- Enrollment
- 1300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.